These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

754 related items for PubMed ID: 15194783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    Altfeld M, Allen TM, Kalife ET, Frahm N, Addo MM, Mothe BR, Rathod A, Reyor LL, Harlow J, Yu XG, Perkins B, Robinson LK, Sidney J, Alter G, Lichterfeld M, Sette A, Rosenberg ES, Goulder PJ, Brander C, Walker BD.
    J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HIV evolution: CTL escape mutation and reversion after transmission.
    Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJ.
    Nat Med; 2004 Mar; 10(3):282-9. PubMed ID: 14770175
    [Abstract] [Full Text] [Related]

  • 5. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 6. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD.
    J Virol; 1999 Dec 01; 73(12):10191-8. PubMed ID: 10559335
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.
    Chen ZW, Shen L, Miller MD, Ghim SH, Hughes AL, Letvin NL.
    J Immunol; 1992 Dec 15; 149(12):4060-6. PubMed ID: 1460291
    [Abstract] [Full Text] [Related]

  • 8. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
    Sanchez-Merino V, Farrow MA, Brewster F, Somasundaran M, Luzuriaga K.
    J Infect Dis; 2008 Jan 15; 197(2):300-8. PubMed ID: 18177249
    [Abstract] [Full Text] [Related]

  • 9. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection.
    Guglietta S, Garbuglia AR, Pacciani V, Scottà C, Perrone MP, Laurenti L, Spada E, Mele A, Capobianchi MR, Taliani G, Folgori A, Vitelli A, Ruggeri L, Nicosia A, Piccolella E, Del Porto P.
    Eur J Immunol; 2005 Sep 15; 35(9):2627-37. PubMed ID: 16114108
    [Abstract] [Full Text] [Related]

  • 10. Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocyte cross-recognition may explain the immune reaction in infected individuals.
    Thorn M, Tang S, Therrien D, Kløverpris H, Vinner L, Kronborg G, Gerstoft J, Corbet S, Fomsgaard A.
    APMIS; 2007 Jun 15; 115(6):757-68. PubMed ID: 17550385
    [Abstract] [Full Text] [Related]

  • 11. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS.
    J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824
    [Abstract] [Full Text] [Related]

  • 12. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM, Pinheiro S, Sayeid-Al-Jamee M, Alabi A, Kaye S, Sabally S, Sarge-Njie R, Njai H, Joof K, Jaye A, Whittle H, Rowland-Jones S, Dorrell L.
    Eur J Immunol; 2005 May 01; 35(5):1445-53. PubMed ID: 15832290
    [Abstract] [Full Text] [Related]

  • 13. The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
    McKinney DM, Lewinsohn DA, Riddell SR, Greenberg PD, Mosier DE.
    J Immunol; 1999 Jul 15; 163(2):861-7. PubMed ID: 10395680
    [Abstract] [Full Text] [Related]

  • 14. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA, Kostense S, Vandenberghe K, Nanlohy NM, De Cuyper IM, Piriou E, Manting EH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Jan 15; 35(1):150-8. PubMed ID: 15593302
    [Abstract] [Full Text] [Related]

  • 15. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K.
    J Virol; 2004 Feb 15; 78(3):1324-32. PubMed ID: 14722287
    [Abstract] [Full Text] [Related]

  • 16. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA.
    Science; 2002 May 24; 296(5572):1439-43. PubMed ID: 12029127
    [Abstract] [Full Text] [Related]

  • 17. Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population.
    Furutsuki T, Hosoya N, Kawana-Tachikawa A, Tomizawa M, Odawara T, Goto M, Kitamura Y, Nakamura T, Kelleher AD, Cooper DA, Iwamoto A.
    J Virol; 2004 Aug 24; 78(16):8437-45. PubMed ID: 15280452
    [Abstract] [Full Text] [Related]

  • 18. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
    Navis M, Schellens IM, van Swieten P, Borghans JA, Miedema F, Kootstra NA, van Baarle D, Schuitemaker H.
    J Infect Dis; 2008 Mar 15; 197(6):871-9. PubMed ID: 18279072
    [Abstract] [Full Text] [Related]

  • 19. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJ.
    Nature; 2004 Dec 09; 432(7018):769-75. PubMed ID: 15592417
    [Abstract] [Full Text] [Related]

  • 20. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL, Tao I, Szeto S, Brumme CJ, Carlson JM, Chan D, Kadie C, Frahm N, Brander C, Walker B, Heckerman D, Harrigan PR.
    AIDS; 2008 Jul 11; 22(11):1277-86. PubMed ID: 18580606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.